Alcon (ALC)
(Delayed Data from NYSE)
$80.92 USD
-1.09 (-1.33%)
Updated May 13, 2024 04:00 PM ET
After-Market: $80.91 -0.01 (-0.01%) 6:20 PM ET
2-Buy of 5 2
B Value C Growth F Momentum C VGM
Price, Consensus and EPS Surprise
ALC 80.92 -1.09(-1.33%)
Will ALC be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ALC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ALC
Why Alcon (ALC) Might Surprise This Earnings Season
Here's How SONY is Placed Just Ahead of Q4 Earnings Release
ALC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
ALC vs. EW: Which Stock Is the Better Value Option?
Are Medical Stocks Lagging DaVita (DVA) This Year?
Other News for ALC
Alcon hails "positive momentum" as quarterly earnings climb
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
Global company events calendar
Alcon Q1 2024: Strong Earnings Growth & Operational Efficiency Drive Buy Rating